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TABLE S1. D8 epitope residues and buried surface area.  
 
Antibody Chain H-bond, salt bridges VdW BSA (Å2) 
VACV-66 HC Q3, Q4, H110, D111s, D112, 
D179, D228s, T229 
N18, R20, L21, F56, P58, 
Y61, K109, H110, D112, 
I115, T168, L170, V181, 
E230, Y232 
1776 
LC R20 N18, A19 306 
VACV-
138 
HC T34, T35, Q37, R44s, N46, K48, 
S65, Y104, E105, K108s, N145, 
S147, N175 
T39, S64, T146, P149 1432 
LC N145 R142, S143, A144, L203 564 
VACV-
304 
HC T34, T35, N46, E105, S140, 
N145, S147 
Q37, N38, T39, N46, F47, 
T146, A148, P149 
1010 






TABLE S2. Antibody-antigen polar contacts 
 
Antibody and H or L chain D8 Antigen CDR Interactiona 
 
VACV-66    
Ser30HO Gln3NE2 H1 H 
Asn32HOD1 Gln4N H1 H 
Asn32HND2 Gln4O H1 H 
Asn32HND2 Gln3OE1 H1 H 
Asn32HND2 Asp179OD1 H1 H 
Asn33HND2 Thr229OG1 H1 H 
Tyr34HOH  Asp228OD2 H1 H 
Tyr35HOH Asp111OD2 H1 H 
Tyr55HOH Gln3OE1 H2 H 
Tyr55HOH Asp179OD2 H2 H 
Ser58HOG Asp111N H2 H 
Ser58HOG His110ND1 H2 H 
Tyr60HOH Asp111OD1 H2 H 
Tyr60HOH Asp111OD2 H2 H 
Tyr60HOH Asp112OD1 H2 H 
Tyr60HOH Asp112OD2 H2 H 
Tyr60HOH Lys100NZ H2 H 




Arg101NH2 Asp228O H3 H 
Arg102NH1 Asp111HO H3 H 
Arg102NH2 Asp111HO H3 H 
VACV-138    
Thr28HOG1 Lys48Nz H1 H 
Asp31HOD2 Thr34OG1 H1 H 
Asp31HOD2 Lys48Nz H1 S 
Asp31HO Gln37NE2 H1 H 
Asp31HO Thr35OG1 H1 H 
Asp52HOD2 Arg44NH1 H2 S 
Asp52HOD1 Arg44NH2 H2 S 
Gln54HOE1 Ser65OG H2 H 
Gln54HNE2 Asn46OD1 H2 H 
Glu55HOE1 Lys108NZ H2 S 
Glu55HOE2 Arg44NH1 H2 S 
Glu55HOE2 Tyr104OH H2 H 
Glu55HO Lys108NZ H2 H 
Glu57OE1 Asn175ND2 H2 H 
Thr74HOG1 Glu105OE2 FR H 
Glu99HOE1 Ser147OG H3 H 
Glu99HOE2 Ser147N H3 H 
Tyr98LOH Asn145ND2 L3 H 
VACV-304    
Asn31HOD1 Asn145ND2 H1 H 
Trp33HNE1 Ser147O H1 H 
Lys52HNZ Ser140OG H2 H 
Gln53HNE2 Ser147OG H2 H 
Gln53HOE1 Ser147N H2 H 
Glu102HO Asn46ND2 H3 H 
Glu102HO Thr35OG1 H3 H 
Glu102HOE1 Thr34OG1 H3 H 
Ala104HN Ser147OG H3 H 
Ser109HN Glu105OE2 H3 H 
Leu27LO Lys48NZ L1 H 
Gln30LO Lys48NZ L1 H 
Asp50LOD1 Lys48NZ L2 S 
Asp50LOD2 Lys48NZ L2 S 
Ser51LOG Lys98NZ L2 H 
Glu52LOE1 Tyr104N L2 H 
Arg53LN Ser102O L2 H 
aHydrogen bond (H), salt-bridge (S)    
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Figure S1. Antibody binding to D8 mutants. BLI experiment using a single dose of indicated MAb to 





Figure S2. D8-CS-E model. Computational model of CS-E (green sticks) binding along the central 
crevice of D8 (in cyan), with individual D8 residues indicated. Predicted polar interactions shown as blue 
dotted lines. GalNAc, N-acetyl galactosamine; GlcA, glucuronic acid. 
	
